Novo Nordisk

Healthcare

Eli Lilly Skyrockets After Promising Results for First Weight-Loss Pill

Photo by JHVEPhoto via iStock

The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.

2 min read

Photo via Novo Nordisk

Healthcare

Coming Soon to an Internet Near You: Half-Price, Direct-to-Consumer Wegovy

Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.

2 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Hims & Hers Struggles After the FDA Puts a Ticking Clock on its Weight-Loss Drug

Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.

2 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Weight-Loss Giants Have Investors Back on Their Side

It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

1 min read

Healthcare

Novo Nordisk May Have Another Blockbuster on its Hands

Photo by News Øresund – Kristoffer Dahl via CC BY 3.0

On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.

1 min read

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Healthcare

Wegovy Finally Gains Regulatory Approval in China

Photo via Novo Nordisk

Novo Nordisk scored approval to sell its Wegovy weight loss drug in China. That’s a big win, but competitors will soon flood in.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.